TiO 2 -Nanoparticle–Enhanced Sonodynamic Therapy for Prevention of Posterior Capsular Opacification and Ferroptosis Exploration of Its Mechanism
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.12.24 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2024. Written by Yuanyuan Li and 7 co-authors. Institution: Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China. Major MEDLINE topics: Ferroptosis, Titanium, Capsule Opacification, Reactive Oxygen Species. Cited 3 times so far (Crossref); 69 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
To explore the application and potential ferroptosis mechanisms of sonodynamic therapy (SDT) using titanium dioxide nanoparticles (TiO2-NPs) as sonosensitizers for the prevention of posterior capsule opacification (PCO).
Methods
We fabricated TiO2-NP-coated intraocular lenses (TiO2-IOLs) using the spin-coating method, followed by ultrasound activation of the photosensitizer TiO2. In vitro experiments were performed with human lens epithelial cells (HLECs) to explore the appropriate concentration of TiO2 and ultrasonic parameters. Investigations included reactive oxygen species (ROS) generation, glutathione (GSH) depletion, glutathione peroxidase 4 (GPX4) western blot analysis, lipid peroxidation assays, and transcriptomics analysis. Finally, TiO2-IOLs were implanted in rabbit eyes to explore the in vivo performance of SDT.
Results
Through both in vitro and in vivo experiments, the study determined that the ultrasound parameters of 5-minute duration, 1-MHz frequency, 50% duty cycle, and 1.2-W/cm2 intensity were reliable and valid for killing HLECs without damaging other ocular structures. In vitro experiments demonstrated that SDT generated excess ROS, which disrupted the mitochondrial membrane potential and significantly reduced the GSH content. Additionally, the downregulation of GPX4, accumulation of lipid peroxides, and alteration of mitochondrial morphology were observed, suggesting that ferroptosis may be the underlying mechanism. The RNA-sequencing analysis results also showed an increase in the expression of multiple pro-ferroptosis genes and the ferroptosis marker gene PTGS2. Animal experiments preliminarily demonstrated the safety and effectiveness of SDT in treating PCO in vivo.
Conclusions
TiO2-IOLs combined with SDT effectively prevented PCO by generating ROS and intracellular ferroptosis.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Eye Hospital and School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, China.
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
- Eye Hospital of Wenzhou Medical University Hangzhou Branch, Hangzhou, China.
Cite
APA
Li, Y., Chang, P., Xu, L., Zhu, Z., Hu, M., Cen, J., Li, S., & Zhao, Y. E. (2024). TiO 2 -Nanoparticle–Enhanced Sonodynamic Therapy for Prevention of Posterior Capsular Opacification and Ferroptosis Exploration of Its Mechanism. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.12.24
Vancouver
Li Y, Chang P, Xu L, Zhu Z, Hu M, Cen J, et al. TiO 2 -Nanoparticle–Enhanced Sonodynamic Therapy for Prevention of Posterior Capsular Opacification and Ferroptosis Exploration of Its Mechanism. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.12.24
BibTeX
@article{Li2024,
author = {Li, Yuanyuan and Chang, Pingjun and Xu, Liming and Zhu, Zehui and Hu, Man and Cen, Jiaying and Li, Siyan and Zhao, Yun-E},
title = {TiO 2 -Nanoparticle–Enhanced Sonodynamic Therapy for Prevention of Posterior Capsular Opacification and Ferroptosis Exploration of Its Mechanism},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.12.24}
}
EUVIMED